News that may have an impact on prices of some stocks today

Promoter entity to sell up to 15% stake in Timex through OFS on June 25^th, 26^th

Promoter Timex Group Luxury Watches B V to sell up to 15% stake via offer for sale (OFS) on June 25 and 26. The company has announced floor price for the issue at Rs 175 per share, a discount of 35% of the current market price. The news is likely to have a negative impact on the stock price.

Aurobindo Pharma gets approval for its biosimilar drug in UK

The company’s arm received Marketing Authorisation from UK’s medicines and healthcare products regulatory agency for Dyrupeg, Pegylated Filgrastim Biosimilar. This is CuraTeQ’s third biosimilar to be approved by MHRA after the approval of Bevqolva in December 2024 and Zefylti in May 2025. The news is likely to have a positive impact on the stock price.

Promoter sells shares of Avalon Technologies

Promoter Bhaskar Srinivasan sold 20.91 lakh shares (3.17%) at Rs 790.5 per share, Bhaskar Srinivasan sold 11.98 lakh shares (1.82%) at Rs 809 per share, Axis Mutual Fund bought 9.6 lakh shares (1.45%) at Rs 790 apiece, Alchemy Emerging Leaders of Tomorrow bought 4.94 lakh shares (0.75%) at Rs 809 apiece.

HCL, AMD to partner for AI, digital and cloud

HCL Tech has joined hands with Nasdaq-listed global semiconductor major AMD to develop solutions across AI, digital and cloud. The strategic alliance will aim to create a digital ecosystem to offer enterprise digital transformation, and both companies will be coinvesting in innovation labs and training programs.

Ericsson projects 5G user base in India to touch 98 crore by 2030

Ericsson projects substantial growth in India’s 5G subscribers by 2030. The 5G user base may reach 98 crore, while 4G users may decline to 23 crore. India currently leads in data traffic per smartphone. Data consumption is also expected to increase. The expansion of 5G FWA is driven by the need for broadband, especially in rural areas.

Infosys gets new client in Zoetis

Infosys announced a strategic collaboration with Zoetis, the world’s leading animal health company. This long-term engagement aims to enhance Zoetis’ IT operations and digital capabilities by integrating advanced AI solutions and automation services, providing greater agility to respond to evolving business landscape and customer needs.

Vodafone, Cyient launch AI powered solution

Vodafone and Cyient, a global Intelligent Engineering solutions company, have launched an AI-powered Global Network Configuration Management solution supported by data-driven, intelligent configuration analytics.

CSB bank extends Mondal’s tenure as MD & CEO by three years

CSB Bank said its board has approved extension of Pralay Mondal as managing director & CEO of the bank for a period of three years. His re-appointment would be effective from September 15, 2025, up to September 14, 2028.

Equitas, Edelweiss Life Insurance to partner for insurance sales

Equitas Small Finance Bank and Edelweiss Life Insurance on Tuesday announced that they have entered into a bancassurance partnership to offer life insurance solutions to the bank’s customers.

Bajel Projects gets new order

Company has secured an order from a leading private player in the energy and power transmission sector. This order falls within the “Large” order band (valued between Rs 100 cr and Rs 200 cr), as per the company’s internal classification. It is to be completed in the 18 months.

RITES gets new order of Rs 28.5 crore

Rites Ltd. received an order worth Rs 28.5 crore (excl. GST) from Gujarat Urban Development Company.

Star Health, Medi Assist to collaborate

Star Health and Allied Insurance Company Ltd. has entered into a strategic partnership with Medi Assist Healthcare Services Limited (Medi Assist), to adopt MAtrix platform, an advanced AI-powered claims platform. This collaboration is a significant step in Star Health’s ongoing claims transformation journey, focused on delivering faster settlements, better customer engagement, and technology-led service excellence. The partnership will help in identification and elimination of fraud and reduction in waste and abuse through AI tools.

JB Chemicals receives USFDA approval for new drug

Company has received approval from United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA), Amitriptyline Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg, which is indicated for relief of symptoms of depression.

Solarium Green receives work order of Rs 35.32 crore

Company has received work order of Rs 35.32 crore, exclusive of GST from Kirloskar Solar Technologies Private Limited for Supply of all the equipment and execution relating to it for the Development of 11775 KW Grid Connected Rooftop Solar Projects at various locations of Central Armed Forces and Department of Ministry of Home Affairs.

Concord Biotech receives USFDA receives EIR

Company has received an Establishment Inspection Report (EIR) from the US FDA for the inspection carried out by them at API facility at Dholka from 28th April 2025 till 2nd May 2025.

 Disclaimer: This content is only for informational purpose. It does not make any recommendation to act or invest. To get any error corrected, write to content@hdfcsec.com.

Source: HDFC Securities Prime Research